Nutrition
-
[corrected] A standard rodent diet for space flight must meet the unique conditions imposed by the space environment and must be nutritionally adequate because diet can influence the outcome of experiments. We evaluated the use of National Aeronautics and Space Administration (NASA) Foodbars as a standard space flight diet for rats. ⋯ Results indicated that NASA Rodent Foodbars meet the physical and nutritional criteria required to support rodents in the space environment and thus may be used successfully as a standard diet for short-term space flight studies. However, the nutritional adequacy of NASA Rodent Foodbars as a standard diet on longer-duration (>20 d) space flight missions remains to be determined.
-
We compared the effects of supplementing with vitamins A, C, and E, selenium, and zinc on a range of innate and specific T-helper 1 (Th1) and Th2-driven adaptive immune responses. ⋯ These findings confirmed that supplementary amounts of vitamin A above dietary requirements enhance inflammatory responses accompanied by decreased Th1 and increased mucosal responses. However, supplementation of these sufficiently fed, non-stressed, young adult mice with vitamins C and E, selenium, or zinc had no effect on immune function. We speculate that using this model in aged, physiologically, or nutritionally stressed mice may provide outcomes more similar to those in sensitive human populations. If so, this would improve the usefulness of the model to assess, characterize, and rank effects of foods or nutrients on a range of immune functions, including Th1/Th2 polarization.
-
We evaluated whether statins, in view of their anti-inflammatory properties, may effectively prevent the onset or modulate the severity of muscle wasting during cancer cachexia. ⋯ Simvastatin administration, although capable of negatively modulating the inflammatory response, did not prevent muscle wasting in this experimental model of cancer cachexia. Moreover, the further muscle loss observed in simvastatin-treated tumor-bearing animals suggests that a note of caution should be introduced in treating cancer patients with statins in view of the possible occurrence of harmful side effects.